Key result
FHL2 overexpression stimulates glioblastoma cell proliferation and tumorigenicity, whereas knockdown inhibits these oncogenic activities.
FHL2 contributes to glioma carcinogenesis by promoting cell proliferation, migration, and tumorigenicity while suppressing proapoptotic pathways.
Answers are grounded in this paper and cite their sources.
FHL2 may be a glioma driver in animal models; human studies needed before therapeutic targeting.
Four-and-a-half-LIM protein 2 (FHL2) is a member of FHL protein family, which plays a crucial role in regulating gene expression, cell survival, and migration. Although its function in oncogenesis appears to be tumor type-specific, its roles in glioma formation and development are yet to be elucidated. In the present study, we demonstrated that the mRNA level of FHL2 was elevated in both low- and high-grade glioma samples. Overexpression of FHL2 stimulated the proliferation, anchorage-independent growth, and migration of human glioblastoma cells. Conversely, FHL2 knockdown by short hairpin RNA (shRNA-FHL2) inhibited glioblastoma cell proliferation and migration. Overexpression of FHL2 increased the tumorigenicity of glioblastoma cells in nude mice and decreased the mRNA levels of p53 and its downstream proapoptotic genes, including p21, Bcl2-associated protein X (Bax), and p53-upregulated modulator of apoptosis. It also enhanced the promoter activities of activator protein-1 (AP-1), human telomerase reverse transcriptase, and survivin genes. Together, these results provide the first evidence that FHL2 contributes to glioma carcinogenesis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2008) studied Glioma. FHL2 overexpression and knockdown was evaluated on Tumorigenicity, cell proliferation, and migration. FHL2 overexpression stimulated proliferation, migration, and tumorigenicity of glioblastoma cells, whereas FHL2 knockdown inhibited these oncogenic activities.
Synapse has enriched 10 related papers. Consider them for comparative context: